Company profile ITCI
After 39 days of this quarter the interest is at 43.0. Based on that we can calculate that during remaining 52 days it will total up to 100.0. intracellular therapies expected interest is significantly higher compared to previous quarter (+143.9%) and same quarter last year (+88.7%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 32 | 49 53.1% QoQ | 75 53.1% QoQ | 94 25.3% QoQ |
| 2020 | 77 140.6% YoY -18.1% QoQ | 32 -34.7% YoY -58.4% QoQ | 59 -21.3% YoY 84.4% QoQ | 13 -86.2% YoY -78.0% QoQ |
| 2021 | 43 -44.2% YoY 230.8% QoQ | 22 -31.2% YoY -48.8% QoQ | 54 -8.5% YoY 145.5% QoQ | 190 1361.5% YoY 251.9% QoQ |
| 2022 | 514 1095.3% YoY 170.5% QoQ | 47 113.6% YoY -90.9% QoQ | 32 -40.7% YoY -31.9% QoQ | 66 -65.3% YoY 106.2% QoQ |
| 2023 | 53 -89.7% YoY -19.7% QoQ | 48 2.1% YoY -9.4% QoQ | 35 9.4% YoY -27.1% QoQ | 41 -37.9% YoY 17.1% QoQ |
| 2024 | 43 -18.9% YoY 4.9% QoQ | - | - | - |
The average 5 years interest of intracellular therapies was 6.2 per week. The last year interest of intracellular therapies compared to the last 5 years has changed by -39.19%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -35.33%.
There is not enough data for intracellular therapies caplyta to provide analysis
There is not enough data for intracellular therapies caplyta to provide correlation calculation
There is not enough data for intracellular therapies caplyta to provide analysis
After 39 days of this quarter the interest is at 267.0. Based on that we can calculate that during remaining 52 days it will total up to 623.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 52 | 351 575.0% QoQ | 317 -9.7% QoQ | 422 33.1% QoQ |
| 2020 | 404 676.9% YoY -4.3% QoQ | 205 -41.6% YoY -49.3% QoQ | 507 59.9% YoY 147.3% QoQ | 196 -53.6% YoY -61.3% QoQ |
| 2021 | 319 -21.0% YoY 62.8% QoQ | 438 113.7% YoY 37.3% QoQ | 401 -20.9% YoY -8.4% QoQ | 492 151.0% YoY 22.7% QoQ |
| 2022 | 521 63.3% YoY 5.9% QoQ | 646 47.5% YoY 24.0% QoQ | 642 60.1% YoY -0.6% QoQ | 715 45.3% YoY 11.4% QoQ |
| 2023 | 699 34.2% YoY -2.2% QoQ | 562 -13.0% YoY -19.6% QoQ | 697 8.6% YoY 24.0% QoQ | 700 -2.1% YoY 0.4% QoQ |
| 2024 | 267 -61.8% YoY -61.9% QoQ | - | - | - |
The average 5 years interest of lumateperone was 36.6 per week. The last year interest of lumateperone compared to the last 5 years has changed by 36.04%. The interest for lumateperone is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 90.77%.
There is not enough data for ITI-214 to provide analysis
There is not enough data for ITI-214 to provide correlation calculation
There is not enough data for ITI-214 to provide analysis
There is not enough data for ITI-1284 to provide analysis
There is not enough data for ITI-1284 to provide correlation calculation
There is not enough data for ITI-1284 to provide analysis
There is not enough data for ITI-333 to provide analysis
There is not enough data for ITI-333 to provide correlation calculation
There is not enough data for ITI-333 to provide analysis
After 39 days of this quarter the interest is at 56.0. Based on that we can calculate that during remaining 52 days it will total up to 131.0. intracellular therapies stock expected interest is significantly higher compared to previous quarter (+47.2%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 68 inf% QoQ | 49 -27.9% QoQ | 224 357.1% QoQ |
| 2020 | 27 inf% YoY -87.9% QoQ | 37 -45.6% YoY 37.0% QoQ | 211 330.6% YoY 470.3% QoQ | 30 -86.6% YoY -85.8% QoQ |
| 2021 | 112 314.8% YoY 273.3% QoQ | 31 -16.2% YoY -72.3% QoQ | 258 22.3% YoY 732.3% QoQ | 159 430.0% YoY -38.4% QoQ |
| 2022 | 260 132.1% YoY 63.5% QoQ | 231 645.2% YoY -11.2% QoQ | 137 -46.9% YoY -40.7% QoQ | 165 3.8% YoY 20.4% QoQ |
| 2023 | 147 -43.5% YoY -10.9% QoQ | 126 -45.5% YoY -14.3% QoQ | 243 77.4% YoY 92.9% QoQ | 89 -46.1% YoY -63.4% QoQ |
| 2024 | 56 -61.9% YoY -37.1% QoQ | - | - | - |
The average 5 years interest of intracellular therapies stock was 10.19 per week. The last year interest of intracellular therapies stock compared to the last 5 years has changed by 14.72%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 78.2%.
There is not enough data for intracellular therapies news to provide analysis
There is not enough data for intracellular therapies news to provide correlation calculation
There is not enough data for intracellular therapies news to provide analysis